Статті в журналах з теми "Bone, Paget, osteoclast, p62"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-28 статей у журналах для дослідження на тему "Bone, Paget, osteoclast, p62".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Hiruma, Yuko, Noriyoshi Kurihara, Diane F. Jelinek, and David Roodman. "Increased Signaling through p62 in the Marrow Microenvironment Increases Myeloma Cell Growth and Osteoclast Formation." Blood 112, no. 11 (November 16, 2008): 642. http://dx.doi.org/10.1182/blood.v112.11.642.642.
Повний текст джерелаLayfield, R., J. R. Cavey, D. Najat, J. Long, P. W. Sheppard, S. H. Ralston, and M. S. Searle. "p62 mutations, ubiquitin recognition and Paget's disease of bone." Biochemical Society Transactions 34, no. 5 (October 1, 2006): 735–37. http://dx.doi.org/10.1042/bst0340735.
Повний текст джерелаIshizuka, Fumito, Jolene Windle, David Roodman, and Noriyoshi Kurihara. "p62 as a Therapeutic Target for Myeloma Cell Growth and Osteoclast Formation." Blood 114, no. 22 (November 20, 2009): 2857. http://dx.doi.org/10.1182/blood.v114.22.2857.2857.
Повний текст джерелаLayfield, Robert. "The molecular pathogenesis of Paget disease of bone." Expert Reviews in Molecular Medicine 9, no. 27 (September 2007): 1–13. http://dx.doi.org/10.1017/s1462399407000464.
Повний текст джерелаSundaram, Kumaran, Srinivasan Shanmugarajan, D. Sudhaker Rao, and Sakamuri V. Reddy. "Mutant p62P392L Stimulation of Osteoclast Differentiation in Paget's Disease of Bone." Endocrinology 152, no. 11 (August 30, 2011): 4180–89. http://dx.doi.org/10.1210/en.2011-1225.
Повний текст джерелаLayfield, Robert, and Mark S. Searle. "Disruption of ubiquitin-mediated processes in diseases of the brain and bone." Biochemical Society Transactions 36, no. 3 (May 21, 2008): 469–71. http://dx.doi.org/10.1042/bst0360469.
Повний текст джерелаHiruma, Yuko, Tadashi Honjo, Diane F. Jelinek, Jolene J. Windle, Jaekyoon Shin, G. David Roodman, and Noriyoshi Kurihara. "Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation." Blood 113, no. 20 (May 14, 2009): 4894–902. http://dx.doi.org/10.1182/blood-2008-08-173948.
Повний текст джерелаSultana, Melanie A., Carmel Cluning, Wai-Sin Kwong, Nicole Polain, Nathan J. Pavlos, Thomas Ratajczak, John P. Walsh, Jiake Xu та Sarah L. Rea. "The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-κB signalling function". PLOS ONE 16, № 11 (4 листопада 2021): e0259556. http://dx.doi.org/10.1371/journal.pone.0259556.
Повний текст джерелаTeramachi, Jumpei, Kyaw Ze Yar Myint, Rentian Feng, Xiangqun Xie, Jolene J. Windle, David Roodman, and Noriyoshi Kurihara. "Blocking the ZZ Domain of Sequestosome 1/p62 Suppress the Enhancement of Myeloma Cell Growth and Osteoclast Formation by Marrow Stromal Cells." Blood 118, no. 21 (November 18, 2011): 888. http://dx.doi.org/10.1182/blood.v118.21.888.888.
Повний текст джерелаKurihara, Noriyoshi, Tadashi Honjo, Jolene J. Windle, J. Shin, and G. D. Roodman. "Targeting p62ZIP in Marrow Stromal Cells Is Highly Effective at Inhibiting Myeloma Cell Growth and Osteoclast Formation." Blood 106, no. 11 (November 16, 2005): 630. http://dx.doi.org/10.1182/blood.v106.11.630.630.
Повний текст джерелаKurihara, Noriyoshi, Y. Hiruma, J. Windle, C. S. Hong, J. Shin, and David Roodman. "Targeting p62 in Marrow Stromal Cells Is Effective at Inhibiting Myeloma Cell Growth." Blood 108, no. 11 (November 16, 2006): 513. http://dx.doi.org/10.1182/blood.v108.11.513.513.
Повний текст джерелаTeramachi, Jumpei, Jolene J. Windle, David Roodman, and Noriyoshi Kurihara. "The ZZ Domain of Sequestosome-1/p62 Plays An Important Role In Stromal Cell Support of Myeloma Cell Growth and Osteoclast Formation." Blood 116, no. 21 (November 19, 2010): 128. http://dx.doi.org/10.1182/blood.v116.21.128.128.
Повний текст джерелаLaurin, Nancy, Jacques P. Brown, Jean Morissette, and Vincent Raymond. "Recurrent Mutation of the Gene Encoding sequestosome 1 (SQSTM1/p62) in Paget Disease of Bone." American Journal of Human Genetics 70, no. 6 (June 2002): 1582–88. http://dx.doi.org/10.1086/340731.
Повний текст джерелаHiruma, Yuko, Noriyoshi Kurihara, and David Roodman. "p62 Signaling Is Increased in Multiple Myeloma Microenvironment." Blood 110, no. 11 (November 16, 2007): 669. http://dx.doi.org/10.1182/blood.v110.11.669.669.
Повний текст джерелаLiu, Chang, Yuan He, Xiaobing Xu та Baorong He. "Phospholipase Cγ Signaling in Bone Marrow Stem Cell and Relevant Natural Compounds Therapy". Current Stem Cell Research & Therapy 15, № 7 (14 жовтня 2020): 579–87. http://dx.doi.org/10.2174/1574888x14666191107103755.
Повний текст джерелаHöppner, Jakob, Katja Steff, Felix Lobert, Christoph M. Heyer, Berthold P. Hauffa, and Corinna Grasemann. "Rhizomelia and Impaired Linear Growth in a Girl with Juvenile Paget Disease: The Natural History of the Condition." Hormone Research in Paediatrics 94, no. 3-4 (2021): 151–58. http://dx.doi.org/10.1159/000517164.
Повний текст джерелаMannino, Federica, and Post Doc. "ODP599 Modulation of Wnt/b-catenin and Autophagy in an in vitro Model of Glucocorticoid-induced Osteoporosis." Journal of the Endocrine Society 6, Supplement_1 (November 1, 2022): A186. http://dx.doi.org/10.1210/jendso/bvac150.384.
Повний текст джерелаSilbermann, Rebecca, Wei Zhao, Julie L. Eiseman, Jan H. Beumer, Xiang-Qun Xie, Peng Yang, Kyaw-Zeyar Myint, et al. "A Novel Sequestosome-1/p62 ZZ Domain Inhibitor Induces New Bone Formation In The Presence Of Myeloma In Vivo." Blood 122, no. 21 (November 15, 2013): 684. http://dx.doi.org/10.1182/blood.v122.21.684.684.
Повний текст джерелаBorsani, Elisa, Veronica Bonazza, Barbara Buffoli, Pier Francesco Nocini, Massimo Albanese, Francesca Zotti, Francesco Inchingolo, Rita Rezzani, and Luigi F. Rodella. "Beneficial Effects of Concentrated Growth Factors and Resveratrol on Human Osteoblasts In Vitro Treated with Bisphosphonates." BioMed Research International 2018 (2018): 1–13. http://dx.doi.org/10.1155/2018/4597321.
Повний текст джерелаSilbermann, Rebecca, Dan Zhou, Jumpei Teramachi, Xiang-Qun Xie, G. David Roodman, and Noriyoshi Kurihara. "The p62-ZZ Domain Inhibitor XRK3F2 Alters Myeloma-Induced Suppression of Osteoblast Differentiation and Is Highly Cytotoxic to Myeloma Cells in Combination with Bortezomib." Blood 124, no. 21 (December 6, 2014): 2083. http://dx.doi.org/10.1182/blood.v124.21.2083.2083.
Повний текст джерелаTeramachi, J., R. Silbermann, P. Yang, W. Zhao, K. S. Mohammad, J. Guo, J. L. Anderson, et al. "Blocking the ZZ domain of sequestosome1/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo." Leukemia 30, no. 2 (August 19, 2015): 390–98. http://dx.doi.org/10.1038/leu.2015.229.
Повний текст джерелаWang, Shumin, Eri O. Maruyama, John Martinez, Justin Lopes, Trunee Hsu, Wencheng Wu, Wei Hsu, and Takamitsu Maruyama. "MicroRNA-27a is essential for bone remodeling by modulating p62-mediated osteoclast signaling." eLife 12 (February 8, 2023). http://dx.doi.org/10.7554/elife.79768.
Повний текст джерелаOh, Sue Young, Namju Kang, Jung Yun Kang, Ki Woo Kim, Jong-Hoon Choi, Yu-Mi Yang, and Dong Min Shin. "Sestrin2 Regulates Osteoclastogenesis via the p62-TRAF6 Interaction." Frontiers in Cell and Developmental Biology 9 (March 26, 2021). http://dx.doi.org/10.3389/fcell.2021.646803.
Повний текст джерелаQin, Huan, Wenwen Zhao, Yang Jiao, Haoyi Zheng, Hao Zhang, Jingyu Jin, Qiu Li, Xiuping Chen, Xia Gao, and Yantao Han. "Aqueous Extract of Salvia miltiorrhiza Bunge-Radix Puerariae Herb Pair Attenuates Osteoporosis in Ovariectomized Rats Through Suppressing Osteoclast Differentiation." Frontiers in Pharmacology 11 (January 21, 2021). http://dx.doi.org/10.3389/fphar.2020.581049.
Повний текст джерелаWen, Cailing, Yuheng Zhou, Yanting Xu, Huijing Tan, Caixia Pang, Haiqian Liu, Kaifei Liu, et al. "The Regulatory Role of GBF1 on Osteoclast Activation Through EIF2a Mediated ER Stress and Novel Marker FAM129A Induction." Frontiers in Cell and Developmental Biology 9 (August 25, 2021). http://dx.doi.org/10.3389/fcell.2021.706768.
Повний текст джерелаLi, Jie, Xinle Li, Daquan Liu, Kazunori Hamamura, Qiaoqiao Wan, Sungsoo Na, Hiroki Yokota та Ping Zhang. "eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice". Cell Death & Disease 10, № 12 (грудень 2019). http://dx.doi.org/10.1038/s41419-019-2159-z.
Повний текст джерелаLi, Mengye, Shengxiang Fu, Zhongyuan Cai, Danyang Li, Li Liu, Di Deng, Rongrong Jin, and Hua Ai. "Dual regulation of osteoclastogenesis and osteogenesis for osteoporosis therapy by iron oxide hydroxyapatite core/shell nanocomposites." Regenerative Biomaterials 8, no. 5 (August 9, 2021). http://dx.doi.org/10.1093/rb/rbab027.
Повний текст джерелаCheng, Cheng, Lan Weiss, Henri Leinonen, Alyaa Shmara, Hong Z. Yin, Timothy Ton, Annie Do, et al. "VCP/p97 inhibitor CB-5083 modulates muscle pathology in a mouse model of VCP inclusion body myopathy." Journal of Translational Medicine 20, no. 1 (January 8, 2022). http://dx.doi.org/10.1186/s12967-021-03186-6.
Повний текст джерела